Rapid antidepressant effects of inhaled GH001 in treatment-resistant depression: results from a phase 2b, double-blind, randomized controlled trial with 6-month follow-up
Speaker: Wieslaw J. Cubala (Medical University of Gdańsk, Department of Psychiatry, Faculty of Medicine, Gdańsk, Poland)